Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Wednesday, August 24, 2011

The FDA 510(k) process is flawed. Patients treated as collateral damage.

Dan Walters' personal story about J&J Biosense Webster Lasso Mapping Catheter (link)

From Bioethics Forum blog

Dan Walter is the author of the book "Collateral Damage" (link)
Dan Walter public profile (link)

Photo

No comments:

Post a Comment